Skip to main content
. 2013 May 1;6:19. doi: 10.1186/1755-7682-6-19

Table 3.

Characteristics of the recurrences

   
1
TIA at 7 months: Negative studies again; TIA at 10 months with paroxysmal atrial fibrillation in the third Holter
2
Acute coronary syndrome at 1 month; TIA at 5 months with paroxysmal atrial fibrillation in the second Holter
3
TIA vs. seizures (3 visits to the emergency room): low INR, associated levetirazetam
4
Stroke at 24 hours: previously negative studies; treatment: LMWH + ASA + atorvastatin
5
Vertebro-basilar stroke at 7 months; previously cardioembolic TIA (INR 5.32)
6
TIA at 16 months with paroxysmal atrial fibrillation in the second Holter
7
Stroke at 10 months (PFO on antiplatelet therapy, anticoagulation treatment is started)
8
Stroke at 15 months (PFO on antiplatelet therapy, anticoagulation treatment is started)
9 Stroke at 23 months; previously cardioembolic TIA (INR 3.28)